The refinancing extends Halozyme's debt maturity profile from 2027/2028 to 2033 at a higher coupon (1.50% vs 0.25%/1.00%), adding ~$1.3B in leverage. The capped call structure limits dilution risk up to ~$208.39 per share. Watch for initial purchasers' exercise of the $200M greenshoe option and any subsequent hedging activity by capped call counterparties that could pressure the stock price near conversion periods.
Price Chart
Executive Summary
Halozyme priced an upsized $1.3 billion private offering of 1.50% convertible senior notes due 2033, with an additional $200 million option for initial purchasers. Net proceeds of ~$1.275 billion (or ~$1.471 billion if the option is exercised) will be used to fund capped call transactions ($162.5M), repurchase ~$652.5M of existing 2027/2028 convertible notes, and for general corporate purposes. The transaction extends the company's debt maturity profile and reduces near-term convertible note overhang, but adds $1.3B in new leverage.
Key Facts
- Priced $1.3 billion aggregate principal amount of 1.50% convertible senior notes due 2033, upsized from $1.05 billion
- Initial conversion price of ~$139.84 per share, representing a 27.5% premium over the $109.68 closing price on September 9, 2026
- Granted a 13-day option to initial purchasers to purchase up to an additional $200 million in notes
- Net proceeds of ~$1.275 billion (or ~$1.471 billion if option exercised) after discounts and expenses
- Will use ~$162.5 million to fund capped call transactions with a cap price of ~$208.39 per share (90% premium)
- Will repurchase ~$151.7M of 0.25% convertible notes due 2027 for ~$217.0M total cost and ~$220.0M of 1.00% convertible notes due 2028 for ~$435.5M total cost
- Remaining proceeds for general corporate purposes including potential acquisitions and strategic transactions
- Capped call transactions reduce potential dilution upon conversion; dilution still occurs if stock exceeds ~$208.39 cap price
- Capped call counterparties may enter derivative transactions affecting HALO stock price around pricing and conversion periods
Financial Impact
New $1.3B debt issuance with $652.5M used to retire existing convertible notes; net new cash inflow of ~$1.275B before capped call cost
Risk Factors
- Dilution risk if stock exceeds ~$208.39 cap price, where capped call protection ends and full dilution applies
- Potential stock price pressure from capped call counterparty hedging activities around pricing and conversion observation periods
- Higher annual interest expense from 1.50% coupon vs 0.25%/1.00% on retired notes increases fixed charges
- Use of proceeds for 'potential acquisitions and strategic transactions creates uncertainty about capital allocation discipline
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001159036-26-000126 |
| Exhibit: ex-991xhaloxpricingpressre.htm | 0001159036-26-000126 |
| Document: 0001159036-26-000126-index-headers.html | 0001159036-26-000126 |
| Document: 0001159036-26-000126-index.html | 0001159036-26-000126 |
| Document: 0001159036-26-000126.txt | 0001159036-26-000126 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | Press Release | $124.54 $125.63 | ▲ +0.88% | ▲ +1.40% | $128.01 (+2.79%) |
Oct 20, 2026 6d ago | Institutional Cluster | $124.83 $124.54 | ▼ −0.23% | ▲ +0.95% | $128.01 (+2.55%) |
Oct 15, 2026 11d ago | PTAB Trial | $121.84 $122.50 | ▼ −0.54% | ▼ −0.12% | $128.01 (−5.06%) |
Oct 15, 2026 11d ago | PTAB Trial | $121.84 $122.50 | ▼ −0.54% | ▼ −0.12% | $128.01 (−5.06%) |
Sep 18, 2026 5w ago | 8-K | $112.45 $111.45 | ▼ −0.89% | ▼ −2.44% | $128.01 (+13.84%) |
Sep 17, 2026 5w ago | Insider Cluster | $112.45 $111.45 | ▼ −0.89% | ▼ −2.44% | $128.01 (+13.84%) |
Aug 19, 2026 9w ago | Insider Cluster | $106.12 $108.17 | ▲ +1.93% | ▲ +1.52% | $128.01 (+20.63%) |
Jul 9, 2026 15w ago | Insider Cluster | $76.20 $76.11 | ▼ −0.12% | ▲ +0.65% | $128.01 (+67.99%) |
Jul 2, 2026 16w ago | Insider Cluster | $80.78 $81.57 | ▲ +0.98% | ▲ +1.45% | $128.01 (+58.47%) |
Jun 3, 2026 20w ago | Insider Cluster | $71.60 $71.53 | ▼ −0.10% | ▲ +2.50% | $128.01 (+78.78%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers